Page last updated: 2024-11-05

trazodone and Astasia-Abasia

trazodone has been researched along with Astasia-Abasia in 2 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wald, J1
Taylor, S1
Scamvougeras, A1
Citarella, S1
Lieto, L1
Serio, E1

Trials

1 trial available for trazodone and Astasia-Abasia

ArticleYear
[Clinical contribution to the study on the effects of trazodone in conversion hysteria].
    La Clinica terapeutica, 1977, Oct-31, Volume: 83, Issue:2

    Topics: Adolescent; Adult; Clinical Trials as Topic; Conversion Disorder; Drug Evaluation; Female; Humans; M

1977

Other Studies

1 other study available for trazodone and Astasia-Abasia

ArticleYear
Cognitive behavioural and neuropsychiatric treatment of post-traumatic conversion disorder: a case study.
    Cognitive behaviour therapy, 2004, Volume: 33, Issue:1

    Topics: Adaptation, Psychological; Adult; Cognitive Behavioral Therapy; Conversion Disorder; Diagnostic and

2004